Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gliclazide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with gliclazide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(gliclazide)		Trials
(gliclazide)		Recent Studies (post-2010) (gliclazide)
9,156187552997214308

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botitsi, E; Mavris, M; Phenekos, C; Siafaka-Kapadai, A; Trapali, M1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and gliclazide

ArticleYear
Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus.
    Metabolism: clinical and experimental, 1992, Volume: 41, Issue:5 Suppl 1

    Topics: Aged; Analysis of Variance; Diabetes Mellitus, Type 2; Gliclazide; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Regression Analysis

1992